There are 2949 resources available
806O - Radical hysterectomy in cervical cancer patients with intraoperatively detected positive lymph node: ABRAX multicentric retrospective cohort study (ENGOT-Cx3/CEEGOG CX2)
Presenter: David Cibula
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA29 - Individualized starting dose of niraparib in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC): A randomized, double-blind, placebo-controlled, phase III trial (NORA)
Presenter: Xiaohua Wu
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA30 - INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
Presenter: Nicoletta Colombo
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
1214O - Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
Presenter: Marie Wislez
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1215O - Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): results from the phase II PRINCEPS trial.
Presenter: Benjamin Besse
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA84 - Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
Presenter: Solange Peters
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1783O - Patient reported outcomes from a randomized phase II trial comparing standard-dose with high-dose twice daily (BID) thoracic radiotherapy (TRT) in limited stage small cell lung cancer (LS SCLC)
Presenter: Bjorn Gronberg
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA38 - Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
Presenter: Yungan Tao
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
910O - Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
Presenter: Ezra Cohen
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
LBA39 - 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck
Presenter: Jean Bourhis
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast